KATIE CASEY: Open Payments
NPI 1225452501 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 74 payments from 24 companies in 2025. Trend: 2023 $2,011 · 2024 $1,184 · 2025 $1,445
Food & beverage: $1,360Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $221 |
| BETA BIONICS, INC. | 3 | $167 |
| Mannkind Corporation | 8 | $154 |
| ABBVIE INC. | 5 | $119 |
| Lilly USA, LLC | 5 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Insulet Corporation | 3 | $71 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
Products named: iLet Bionic Pancreas, AFREZZA, Ozempic, JARDIANCE, MOUNJARO, Omnipod, Kerendia, VRAYLAR.
Industry payments across MO — which companies pay providers there.
